A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

BACKGROUND: Peripheral vascular disease of the lower extremities comprises a clinical spectrum that extends from no symptoms to presentation with critical limb ischemia (CLI). Bone marrow derived Mesenchymal Stem Cells (BM- MSCs) may ameliorate the consequences of CLI due to their combinatorial pote...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gupta, Pawan K, Chullikana, Anoop, Parakh, Rajiv, Desai, Sanjay, Das, Anjan, Gottipamula, Sanjay, Krishnamurthy, Sagar, Anthony, Naveen, Pherwani, Arun, Majumdar, Anish S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3688296/
https://ncbi.nlm.nih.gov/pubmed/23758736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-143
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia